Barbara Heckmann

Learn More
An open-label, randomized, controlled, crossover clinical trial of metabolic control and patient preference I mproving metabolic control can reduce complications in type 2 diabetes (1– 4). Conventional insulin therapy (CIT) and flexible intensive insulin therapy (FIT) are treatment options in insulin dependent type 2 diabetic patients. In CIT, participants(More)
BACKGROUND Prospective, observational studies that enroll large numbers of patients with few exclusion criteria may better reflect actual ongoing clinical experience than randomized clinical trials. Our purpose was to obtain efficacy and safety information from a cohort of subjects exposed to latanoprost/timolol fixed combination (FC) for ≥18 months using a(More)
  • 1